Clinical trials recruiting for Atopic Dermatitis (AD)
20
Recruiting trials
19
US states with sites
15
Countries
30%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Texas | 3 |
| Indiana | 2 |
| Pennsylvania | 2 |
| Alabama | 1 |
| Arkansas | 1 |
| California | 1 |
| Florida | 1 |
| Georgia | 1 |
| Illinois | 1 |
| Kentucky | 1 |
| Michigan | 1 |
| Nevada | 1 |
Top cities
San Antonio, Texas 2Arlington, Texas 1Atlanta, Georgia 1Auburn Hills, Michigan 1Bay City, Michigan 1Beverly Hills, California 1Birmingham, Alabama 1Camp Hill, Pennsylvania 1Canton, Ohio 1Chicago, Illinois 1
Self-screener
Recruiting trials
- A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.
- A Phase 1 Clinical Study Comparing GS101 and Dupixent® After Subcutaneous Injection
- A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis
- A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD)
- A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis
- Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic Dermatitis
- CeraVe Effect on Restoring Skin Hydration as Maintenance Regimen in Subjects With Mild to Moderate Atopic Dermatitis
- Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function
- Effect of an Emollient Cream Containing a Milk Bioactive Peptide on Clinical Signs, Pruritus and Bacterial Colonization of Mild Atopic Dermatitis Skin Lesions in Pediatric Population
- Evaluation by Confocal Reflectance Microscopy of the Skin Structure of Patients With Atopic Dermatitis Treated With Tralokinumab Biotherapy.
- Global Healthcare Study on Atopic Dermatitis
- Herbal Ointment in Treating Atopic Dermatitis Topically
- Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
- Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.
- Reflectance Confocal Microscopy Evaluation of Skin Structure of Patients With Atopic Dermatitis Under Nemolizumab
- SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
- Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
- Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease
- The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis
Related conditions
Trials recruiting for Atopic Dermatitis (AD) often also study these conditions. Each links to its own recruiting-trial list.
Eczema 196Atopic Dermatitis (Eczema) 12Psoriasis (PsO) 17Psoriasis 233Lupus 332Atopic dermatitis 126Skin Diseases 5Rheumatoid arthritis 314Psoriatic Arthritis (PsA) 18Hidradenitis Suppurativa (HS) 4
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Atopic Dermatitis (AD) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.